Viamet Pharmaceuticals Garners $7,000,000 Series C Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d2df893f-7f81-44c6-a50f-b60c343be838
Date
6/17/2013
Company Name
Viamet Pharmaceuticals
Mailing Address
4505 Emperor Blvd. Durham, NC 27703 USA
Company Description
Viamet Pharmaceuticals discovers and develops best-in-class inhibitors of validated metalloenzymes via an innovative and proprietary metal-binding approach, our Metallophile Technology.
Website
http://www.viamet.com
Transaction Type
Venture Equity
Transaction Amount
$7,000,000
Transaction Round
Series C
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing-amended.
M&A Terms
Venture Investor